Scott Hadland is pediatrician and addiction specialist at Boston Medical Center and Boston University School of Medicine. Dr. Hadland’s clinical and research interests focus on youth substance use and improving care for young people who use heroin and prescription opioids. His work has been published in leading journals, including The Lancet, Pediatrics, JAMA Pediatrics, and Addiction. Dr. Hadland was the 2016 recipient of the New Investigator Award from the Society for Adolescent Health and Medicine and has received funding from the Thrasher Research Fund, Society for Adolescent Health and Medicine, and National Institute on Drug Abuse.
Boston University School of Medicine
Clinical Addiction Research and Education Unit
Evans Center for Interdisciplinary Biomedical Research
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 91 results.
Faherty LJ, Hadland SE, Stein BD, Patrick SW. Multiplying the Impact of Opioid Settlement Funds by Investing in Primary Prevention. J Hosp Med. 2020 Oct; 15(10):625-627. PMID: 32853139
Earlywine JJ, Hadland SE, Raifman J. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995-2017: A difference-in-differences analysis. PLoS Med. 2020 09; 17(9):e1003272.View Related Profiles. PMID: 32976539
Hadland SE, Jent VA, Alinsky RH, Marshall BDL, Mauro PM, Cerdá M. Opioid Use Disorder Treatment Facilities With Programs for Special Populations. Am J Prev Med. 2020 09; 59(3):e125-e133. PMID: 32448551
Alinsky RH, Hadland SE, Matson PA, Cerda M, Saloner B. Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder. J Adolesc Health. 2020 Oct; 67(4):542-549. PMID: 32336560
Hadland SE, Cerdá M, Earlywine JJ, Krieger MS, Anderson TS, Marshall BDL. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018. JAMA Pediatr. 2020 Apr 01; 174(4):385-387. PMID: 31961384
Goedel WC, Shapiro A, Cerdá M, Tsai JW, Hadland SE, Marshall BDL. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States. JAMA Netw Open. 2020 04 01; 3(4):e203711. PMID: 32320038
Alinsky RH, Zima BT, Rodean J, Matson PA, Larochelle MR, Adger H, Bagley SM, Hadland SE. Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults. JAMA Pediatr. 2020 Mar 01; 174(3):e195183.View Related Profiles. PMID: 31905233
Hadland SE, Bagley SM. Opioid Prescribing Patterns and Subsequent Overdose. JAMA Pediatr. 2020 Feb 01; 174(2):124-125.View Related Profiles. PMID: 31841582
Hadland SE, Chadi N. Through the Haze: What Clinicians Can Do to Address Youth Vaping. J Adolesc Health. 2020 01; 66(1):10-14. PMID: 31866054
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.